Friday, July 10, 2026

pharma · COVID19 · COVID-19 Pandemic

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
1985 Founded
656 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1985
Employees
656
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Trials

Livzon Pharmaceutical Group clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Livzon Pharmaceutical Group programs — each row shows trial ID, program name, phase, status, and indication.

Livzon Pharmaceutical Group trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Livzon Pharmaceutical Group.

  1. Recombinant SARS-CoV-2 fusion protein vaccine (V-01) — Phase 3

    Clinical update
  2. Recombinant SARS-CoV-2 Fusion Protein Vaccine — Phase 1

    Clinical update

Trial registry

2 studies